Zentiva Bolsters Branded Interests With Bid For Apontis Takeover
€10-Per-Share Offer Values German ‘Single Pill Company’ At €85m
Zentiva has launched a bid to take control of German “single pill company” Apontis Pharma, with a €10-per-share offer that values the enterprise at €85m. If successful, Zentiva plans to establish the firm as a standalone branded division.
